Accretion Pharmaceuticals SME IPO...
13 May, 2025
Broach Lifecare Hospital Limited IPO And Its GMP
Broach Lifecare Hospital Limited operates boutique Hospitals under the brand “Maple Hospitals” and provides dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as 2D Echocardiography, Electrocardiography, Treadmill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography Subsequently, in the year June/July 2023 they have ventured into interventional cardiac services such as coronary angiography and stenting, percutaneous coronary intervention (“PCI”) and primary PCI for acute myocardial infarction as a division.
They also provide Balloon mitral-valvuloplasty, permanent pacemaker implantation, cardiac resynchronisation procedures, implantable cardioverter-defibrillator (“AICD”) implantation and procedures for congenital ailments such as coarctation of aorta, stenting and posterior descending artery closure. They also offer a complete range of diagnostic and therapeutic options such as endovascular revascularization, deep vein thrombosis treatment and peripheral angioplasty.
IPO Size: ₹4.02 crores
Issue Type: Fixed price
Shares Offered: 16.08 lakh shares (fresh issue)
Offer for Sale: ₹0.00 crore (no shares are being offered for sale by existing shareholders)
Opening Date: August 13, 2024
Closing Date: August 16, 2024
Book Running Lead Manager: Fedex Securities Pvt Ltd
Registrar: Kfin Technologies Limited
Market Maker: Aftertrade Broking
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Broach Lifecare Hospital Limited IPO And Its GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | 25 | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Broach Lifecare Hospital Limited IPO And Its GMP Details
| Detail | Description |
|---|---|
| IPO Date | August 13, 2024 to August 16, 2024 |
| Listing Date | - |
| Face Value | ₹10 per share |
| Price Band | ₹25 per share |
| Lot Size | 6000 Shares |
| Total Issue Size | 1,608,000 shares (aggregating up to ₹4.02 Cr) |
| Fresh Issue | 1,608,000 shares (aggregating up to ₹4.02 Cr) |
| Offer for Sale | - |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding pre issue | 4,462,380 |
| Shareholding post issue | 6,070,380 |
| Market Maker portion | 84,000 shares Aftertrade Broking |
Broach Lifecare Hospital Limited IPO And Its GMP Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Tuesday, August 13, 2024 |
| IPO Close Date | Friday, August 16, 2024 |
| Basis of Allotment | Monday, August 19, 2024 |
| Initiation of Refunds | Tuesday, August 20, 2024 |
| Credit of Shares to Demat | Tuesday, August 20, 2024 |
| Listing Date | Wednesday, August 21, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 16, 2024 |
Broach Lifecare Hospital Limited IPO And Its GMP Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 6000 | ₹150,000 |
| Retail (Max) | 1 | 6000 | ₹150,000 |
| HNI (Min) | 2 | 12000 | ₹300,000 |
Broach Lifecare Hospital IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Retail Shares Offered | 50% of the Net Issue |
| Other Shares Offered | 50% of the Net Issue |
Broach Lifecare Hospital Limited IPO And Its GMP Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 86.74% | 63.77% |
Company & Financials
Incorporated in 2023, Broach Lifecare Hospital Limited operates boutique hospitals under the brand name "Maple Hospitals. The company provide dedicated 24-hour services to patients with heart ailments, including non-invasive cardiology services such as 2D Echocardiography, Electrocardiography, Treadmill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test and Dobutamine Stress Echocardiography. The Bharuch hospital has 25 ultra-luxury in-patient beds and is equipped with diagnostic devices for various tests. It also provides high-end coronary care and life-saving equipment such as an Intra-aortic Balloon Pump Machine, bic defibrillator and ventilator. The company's hospitals are NABH-certified as small primary-level healthcare organizations. Additionally, they have received certification from the Atomic Energy Regulatory Board for the PACS System and a fire safety certificate from local regulatory bodies to ensure patient safety. They are also a member of Globe BioCare for biomedical waste disposal.
As of August 2024, the company's hospitals are affiliated with 4 PSU insurance companies, 15 private insurance companies, and 8 third-party administrators (TPAs).
Competitive Strength:
- -
Broach Lifecare Hospital Limited IPO And Its GMP Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Total Borrowing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2024 | 571.62 | 260.58 | 69.76 | 546.92 | 100.68 | |||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 12.75% |
| ROCE | 12.77% |
| RoNW | 12.75% |
| P/BV | 2.04 |
| PAT Margin (%) | 26.77 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.56 | 1.15 |
| P/E (x) | 15.99 | 21.75 |
Objectives of Broach Lifecare Hospital IPO
The company proposes to utilise the Net Proceeds from the Issue towards the following objectives:
- 1. Purchase of Machineries.
- 2. Development of a Medical Tourism Web Portal; and
- 3. General Corporate Purpose
Broach Lifecare Hospital IPO Review
The company is in the healthcare segment running multi-speciality hospitals in and around Bharuch. It posted a mixed bag of financial performance as a proprietorship concern and as a corporate entity. Based on FY24 earnings, the issue is relatively aggressively priced. A small equity base post-IPO indicates a longer gestation period for migration. There is no harm in skipping this relatively pricey issue.
RHP:
DRHP:
Read more :
- Solve Plastic Products Limited IPO And Its GMP
- Forcas Studio Limited IPO And Its GMP
- Interarch Building Products Limited IPO And Its GMP
Frequently asked Questions (FAQs )
-
What is Broach Lifecare Hospital IPO?
Broach Lifecare Hospital IPO is an NSE SME IPO. They are going to raise ₹4.02 Crores via IPO. The issue is priced at ₹25 per equity share. The IPO is to be listed on BSE.
-
When will Broach Lifecare Hospital IPO open?
The IPO is to open on August 13, 2024 for QIB, NII, and Retail Investors.
-
What is Broach Lifecare Hospital IPO Investors Portion?
The investors’ portion for QIB is 0%, NII is 50%, and Retail is 50%.
-
What is Broach Lifecare Hospital IPO Size?
Broach Lifecare Hospitals IPO size is ₹4.02 crores.
-
What is the Broach Lifecare Hospital IPO Price Band?
Broach Lifecare Hospital IPO Price Band is ₹25 per equity share.
